VEGFA and colorectal cancer: At present, antibody-based drugs, including those targeting vascular endothelial growth factor, are used clinically as molecularly targeted therapeutic agents for gastrointestinal cancer, resulting in improved prognosis in unresectable advanced colorectal cancer [19].